BRNS
Barinthus Biotherapeutics plc
NASDAQ · Healthcare · Biotechnology · GB
$0.76
+5.50%Leverage
- Debt / equity
- 0.18x
- Net debt / equity
- -0.86x
- Debt / assets
- 0.13x
- Debt / EBITDA
- -0.27x
- Net debt / EBITDA
- 1.31x
Liquidity & coverage
- Current ratio
- 5.54x
- Quick ratio
- 5.54x
- Cash ratio
- 5.19x
- Interest coverage
- -842.20x
- EBITDA / interest
- -708.49x
- Working capital
- $51.9M
Cash & dividend
- FCF / debt
- -2.57x
- Cash flow / debt
- -2.57x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026